Satsuma Pharmaceuticals Inc (STSA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 15,835 | 42,258 | 53,862 | 102,220 | 36,326 |
| Marketable Securities | 77,315 | 65,254 | 67,302 | 30,900 | 31,910 |
| TOTAL | $99,848 | $109,956 | $126,226 | $136,414 | $73,786 |
| Non-Current Assets | |||||
| PPE Net | 6,792 | 7,675 | 7,130 | 7,007 | 6,473 |
| Investments And Advances | 2,620 | 2,634 | 0 | 0 | 0 |
| Other Non-Current Assets | 572 | 2,030 | 1,963 | 636 | 774 |
| TOTAL | $9,984 | $12,339 | $9,093 | $7,643 | $7,247 |
| Total Assets | $109,832 | $122,295 | $135,319 | $144,057 | $81,033 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,080 | 1,573 | 2,062 | 1,993 | 1,990 |
| Accounts payable and accrued liabilities | 1,469 | 1,646 | 3,107 | 1,142 | 3,381 |
| Accrued Expenses | 5,943 | 3,403 | 2,406 | 2,214 | 2,675 |
| TOTAL | $8,492 | $6,622 | $7,575 | $5,349 | $8,046 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | 556 | 1,042 |
| Other Non-Current Liabilities | 0 | 0 | 5 | 7 | 9 |
| TOTAL | $N/A | $N/A | $5 | $563 | $1,051 |
| Total Liabilities | $8,492 | $6,622 | $7,580 | $5,912 | $9,097 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 31,546 | 31,529 | 31,529 | 31,529 | 31,521 |
| Common Shares | 3 | 3 | 3 | 3 | 2 |
| Retained earnings | -141,736 | -126,185 | -112,853 | -101,021 | -90,564 |
| Other shareholders' equity | -42 | -12 | -5 | 3 | 29 |
| TOTAL | $101,340 | $115,673 | $127,739 | $138,145 | $71,936 |
| Total Liabilities And Equity | $109,832 | $122,295 | $135,319 | $144,057 | $81,033 |